Publications

Elmously A, Gray KD, Ullmann TM, Fahey TJ, Afaneh C, Zarnegar R.  2018.  Robotic Reoperative Anti-reflux Surgery: Low Perioperative Morbidity and High Symptom Resolution.. World J Surg. 42(12):4014-4021.

Zhao Y, Wang W, Min I, Wyrwas B, Moore M, Zarnegar R, Fahey TJ.  2017.  BRAF V600E-dependent role of autophagy in uveal melanoma.. J Cancer Res Clin Oncol. 143(3):447-455.

Min IM, Shevlin E, Vedvyas Y, Zaman M, Wyrwas B, Scognamiglio T, Moore MD, Wang W, Park S, Park S et al..  2017.  CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.. Clin Cancer Res. 23(24):7569-7583.

Panjwani S, Moore MD, Gray KD, Finnerty BM, Beninato T, Brunaud L, Fahey TJ, Zarnegar R.  2017.  The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.. Ann Surg Oncol. 24(12):3617-3623.

Moore MD, Afaneh C, Gray KD, Panjwani S, Fahey TJ, Pomp A, Zarnegar R.  2017.  The impact of the robotic platform on assistant variability in complex gastrointestinal surgery.. J Surg Res. 219:98-102.

Moore MD, Panjwani S, Gray KD, Finnerty BM, Zarnegar R, Fahey TJ.  2017.  The role of molecular diagnostic testing in the management of thyroid nodules.. Expert Rev Mol Diagn. 17(6):567-576.

Wang W, Kang H, Zhao Y, Min I, Wyrwas B, Moore M, Teng L, Zarnegar R, Jiang X, Fahey TJ.  2017.  Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.. J Clin Endocrinol Metab. 102(2):634-643.

Wang W, Kang H, Zhao Y, Min I, Wyrwas B, Moore M, Teng L, Zarnegar R, Jiang X, Fahey TJ.  2017.  Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.. J Clin Endocrinol Metab. 102(2):634-643.

Moore M, Panjwani S, Mathew R, Crowley M, Liu Y-F, Aronova A, Finnerty B, Zarnegar R, Fahey TJ, Scognamiglio T.  2017.  Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.. Endocr Pathol. 28(4):339-344.